The available antiviral drugs against coronavirus disease 2019 (COVID-19) are limited. Oral
drugs that can be prescribed to non-hospitalized patients are required. The 4′-fluoruridine …

An accurate, sensitive and selective RP-HPLC-UV method has been established for the
estimation of Molnupiravir (MOL) in pure bulk powder and pharmaceutical formulation …

Молнупиравир является противовирусным препаратом с широким спектром активности
в отношении РНК-вирусов. Проведён анализ безопасности молнупиравира в …

Abstract Coronavirus Disease 2019 (COVID-19) vaccination has resulted in excellent
protection against fatal disease, including in older adults. However, risk factors for post …

Background: Molnupiravir, N4-hydroxycytidine-5'-isopropyl ester, is an oral prodrug of N4-
deoxycytidine (NHC), a nucleoside analog, which has in vitro activity against SARS-CoV-2 …

After almost three years of the pandemic, Severe Acute Respiratory Syndrome Coronavirus
2 (SARS-CoV-2) is still spreading around the world, causing notable sanitary and social …

Background: One of the basic principles for the treatment of COVID-19 patients is the early
initiation of etiotropic therapy. The evidence base for assessment of the efficacy and safety of …

Цель исследования–оценить эффективность и переносимость препарата
молнупиравир у взрослых амбулаторных пациентов с нетяжелым течением COVID-19 …

Background: Molnupiravir is an oral anti-viral that inhibits SARS-CoV-2 replication and
reduces viral load. We aimed to investigate mortality rates and the factors affecting mortality …

After almost three years of the pandemic, Severe Acute Respiratory Syndrome Coronavirus
2 (SARS-CoV-2) is still spreading around the world, causing notable sanitary and social …